Recently, several studies [18–20] had demonstrated that serum sclerostin levels between RA patients and controls were not significantly different, and Mehaney et al. had further revealed that there was no significant correlation between serum sclerostin level and disease activity and bone mineral density. The gene discussed is SOST; the disease is rheumatoid arthritis.